Earnings History Data for Magenta Therapeutics, Inc. (MGTA) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Magenta Therapeutics, Inc.

Magenta Therapeutics Inc. is a clinical-stage biotechnology company. It engaged in developing therapeutics focused on critical areas of unmet need in the field of bone marrow transplant for patients with autoimmune diseases, blood cancers and genetic diseases. Magenta Therapeutics Inc. is headquartered in Cambridge, Mass.

Release Date	Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
16-05-2022	PM	MGTA	Magenta Therapeutics	57.00	-0.39	-0.34	0.00	Magenta Therapeutics GAAP EPS of -$0.39 [5/16/2022 9:23 AM]	1.09	-0.05 (-4.39%)	1.19	0.05 (4.39%)	0.92 - 12.98	245,793	420,000	1,326
Magenta Therapeutics GAAP EPS of -$0.39 [5/16/2022 9:23 AM] Magenta Therapeutics Reports First Quarter Financial Results, Early Clinical Observations from MGTA-117 Clinical Trial and Other Program Highlights [May-16-22 08:00AM] After Plunging 49.1% in 4 Weeks, Here's Why the Trend Might Reverse for Magenta Therapeutics, Inc. (MGTA) [May-16-22 09:35AM] Magenta Therapeutics Reveals Encouraging Interim Data From Lowest Dose Of MGTA-117 In Leukemia Trial [May-16-22 12:29PM]
06-05-2021	PM	MGTA	Magenta Therapeutics, Inc.	564.77	-0.36	-0.40	-0.51	Magenta Therapeutics EPS beats by $0.04 [5/6/2021 8:54 AM]	10.54	-0.80 (-7.05%)	11.34	0.0 (0.00%)	6.03 - 14.20	118,408	120,000	252
Magenta Therapeutics EPS beats by $0.04 [5/6/2021 8:54 AM] Magenta Therapeutics Reports First Quarter Financial Results and Recent Program Highlights [May-06-21 08:00AM]
03-03-2021	PM	MGTA	Magenta Therapeutics, Inc.	534.00	-0.38	-0.43	0.00	Magenta Therapeutics EPS beats by $0.02 [3/3/2021 9:34 AM]	12.99	1.18 (9.99%)	0.0	0.0 (0.00%)	5.76 - 13.54	734,777	477,150	0
Magenta Therapeutics EPS beats by $0.02 [3/3/2021 9:34 AM] Magenta Therapeutics Reports Fourth Quarter and Full-Year 2020 Financial Results and Recent Program Highlights [Mar-03-21 08:00AM]
03-03-2021	PM	MGTA	Magenta Therapeutics, Inc.	507.69	-0.38	-0.43	-0.59	Magenta Therapeutics EPS beats by $0.02 [3/3/2021 9:34 AM]	11.85	0.04 (0.34%)	11.76	-0.05 (-0.42%)	5.76 - 12.63	19,272	477,150	752
Magenta Therapeutics EPS beats by $0.02 [3/3/2021 9:34 AM] Magenta Therapeutics Reports Fourth Quarter and Full-Year 2020 Financial Results and Recent Program Highlights [Mar-03-21 08:00AM]